Publication | Open Access

Nanomicellar formulation of coenzyme Q10 (Ubisol-Q10) effectively blocks ongoing neurodegeneration in the mouse 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine model: potential use as an adjuvant treatment in Parkinson's disease

Alzheimer's DiseaseCoenzyme Q10MedicineMolecular BiologyNanomicellar FormulationNeuropharmacologyAdjuvant TreatmentNeurochemical BiomarkersNeuroprotectionMolecular NeurobiologyNeurodegenerationPharmacologyBiomolecular Engineering